Compile Data Set for Download or QSAR
maximum 50k data
Found 377 with Last Name = 'yasoshima' and Initial = 'k'
TargetSerine/threonine-protein kinase WNK1(Homo sapiens (Human))
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50258546(CHEMBL4087727)
Affinity DataKi:  32nMAssay Description:Allosteric inhibition of WNK1 (unknown origin) expressed in HEK293 cells co-expressing flag-OSR1 assessed as reduction in sorbitol-stimulated OSR1 ph...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase WNK1 [166-489](Homo sapiens (Human))
Novartis Institutes

LigandPNGBDBM203827(N-(tert-butyl)-1-(1-(5-(5-(trifluoromethyl)-1,3,4-...)
Affinity DataIC50:  1nMpH: 7.3 T: 2°CAssay Description:Each well of the MBP-coated ScintiPlates held 100 ul of a solution containing 20 mM HEPES pH 7.3, 5 mM MnCl2 (WNK1 and WNK4) or 3 mM MnCl2 (WNK2 and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Bayer Yakuhin

Curated by ChEMBL
LigandPNGBDBM50344367(1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(7-hydrox...)
Affinity DataIC50:  2.20nMAssay Description:Antagonist activity at human TRPV1 expressed in CHOluc9aeq cells assessed as inhibition of capsaicin-stimulated response by aequorin and CRE-lucifear...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Bayer Yakuhin

Curated by ChEMBL
LigandPNGBDBM50382237(CHEMBL2024668)
Affinity DataIC50:  3.30nMAssay Description:Antagonist activity at human TRPV1 expressed in CHOluc9aeq cells assessed as inhibition of capsaicin-stimulated response by aequorin and CRE-lucifear...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Bayer Yakuhin

Curated by ChEMBL
LigandPNGBDBM50382237(CHEMBL2024668)
Affinity DataIC50:  3.30nMAssay Description:Antagonist activity at human TRPV1 expressed in CHOluc9aeq cells assessed as inhibition of capsaicin-stimulated response by aequorin and CRE-lucifear...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGonadotropin-releasing hormone receptor(Rattus norvegicus)
Kyoto 619-0216

Curated by ChEMBL
LigandPNGBDBM50160523(1-Benzyl-2-[2-(3-tert-butyl-ureido)-ethyl]-1H-benz...)
Affinity DataIC50:  3.90nMAssay Description:Inhibitory concentration of the compound towards rat leutinizing releasing hormone receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase WNK1(Homo sapiens (Human))
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50258566(CHEMBL4088706)
Affinity DataIC50:  4nMAssay Description:Allosteric inhibition of recombinant human N-terminal GST-tagged WNK1 catalytic domain (1 to 491 residues) expressed in baculovirus expression system...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGonadotropin-releasing hormone receptor(Homo sapiens (Human))
Kyoto 619-0216

Curated by ChEMBL
LigandPNGBDBM50160523(1-Benzyl-2-[2-(3-tert-butyl-ureido)-ethyl]-1H-benz...)
Affinity DataIC50:  4.20nMAssay Description:Inhibitory concentration of the compound towards human leutinizing releasing hormone receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase WNK1 [1-491](Homo sapiens (Human))
Novartis Institutes

LigandPNGBDBM203827(N-(tert-butyl)-1-(1-(5-(5-(trifluoromethyl)-1,3,4-...)
Affinity DataIC50:  5nMpH: 7.3 T: 2°CAssay Description:Each well of the MBP-coated ScintiPlates held 100 ul of a solution containing 20 mM HEPES pH 7.3, 5 mM MnCl2 (WNK1 and WNK4) or 3 mM MnCl2 (WNK2 and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase WNK1(Homo sapiens (Human))
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50258547(CHEMBL4098876)
Affinity DataIC50:  6nMAssay Description:Allosteric inhibition of recombinant human N-terminal GST-tagged WNK1 catalytic domain (1 to 491 residues) expressed in baculovirus expression system...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM585716(8-chloro-1-(2,6-dichlorophenyl)-5- ((2-(2-(2-(2- h...)
Affinity DataIC50:  6nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase WNK1 [1-434](Homo sapiens (Human))
Novartis Institutes

LigandPNGBDBM203827(N-(tert-butyl)-1-(1-(5-(5-(trifluoromethyl)-1,3,4-...)
Affinity DataIC50:  6nMpH: 7.3 T: 2°CAssay Description:Each well of the MBP-coated ScintiPlates held 100 ul of a solution containing 20 mM HEPES pH 7.3, 5 mM MnCl2 (WNK1 and WNK4) or 3 mM MnCl2 (WNK2 and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM585717(8-chloro-1-(2,6-dichlorophenyl)-5- (2,3-dihydroxyp...)
Affinity DataIC50:  8nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM585715(N-(2-((8-chloro-1-(2,6- dichlorophenyl)-2-methyl-4...)
Affinity DataIC50:  9nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM585727(8-chloro-1-(2,6-dichlorophenyl)-5- (2-hydroxyethox...)
Affinity DataIC50:  9nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase WNK1 [1-444](Homo sapiens (Human))
Novartis Institutes

LigandPNGBDBM203827(N-(tert-butyl)-1-(1-(5-(5-(trifluoromethyl)-1,3,4-...)
Affinity DataIC50:  9nMpH: 7.3 T: 2°CAssay Description:Each well of the MBP-coated ScintiPlates held 100 ul of a solution containing 20 mM HEPES pH 7.3, 5 mM MnCl2 (WNK1 and WNK4) or 3 mM MnCl2 (WNK2 and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Bayer Yakuhin

Curated by ChEMBL
LigandPNGBDBM50382245(CHEMBL2024494)
Affinity DataIC50:  9.10nMAssay Description:Antagonist activity at human TRPV1 expressed in CHOluc9aeq cells assessed as inhibition of capsaicin-stimulated response by aequorin and CRE-lucifear...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM585729(8-chloro-1-(2,6-dichlorophenyl)-2- methyl-5-(oxeta...)
Affinity DataIC50:  11nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGonadotropin-releasing hormone receptor(Rattus norvegicus)
Kyoto 619-0216

Curated by ChEMBL
LigandPNGBDBM50160511(1-Benzyl-2-[2-(3-tert-butyl-ureido)-ethyl]-1H-benz...)
Affinity DataIC50:  12nMAssay Description:Inhibitory concentration of the compound towards rat leutinizing releasing hormone receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM585719(8-chloro-1-(2,6-chlorophenyl)-5- (2,3-dihydroxy-3-...)
Affinity DataIC50:  13nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM585741(US11530213, Example 62)
Affinity DataIC50:  13nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM585738(US11530213, Example 59)
Affinity DataIC50:  14nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGonadotropin-releasing hormone receptor(Rattus norvegicus)
Kyoto 619-0216

Curated by ChEMBL
LigandPNGBDBM50160515(1-Benzyl-2-[2-(3-tert-butyl-ureido)-ethyl]-1H-benz...)
Affinity DataIC50:  14nMAssay Description:Inhibitory concentration of the compound towards rat leutinizing releasing hormone receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM585718((S)-8-chloro-1-(2,6- dichlorophenyl)-5-((2,3- dihy...)
Affinity DataIC50:  15nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM585721(8-chloro-1-(2,6-dichlorophenyl)-5- (2-hydroxy-2-me...)
Affinity DataIC50:  15nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM585742(US11530213, Example 63)
Affinity DataIC50:  16nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Bayer Yakuhin

Curated by ChEMBL
LigandPNGBDBM50382240(CHEMBL2024667)
Affinity DataIC50:  16nMAssay Description:Antagonist activity at human TRPV1 expressed in CHOluc9aeq cells assessed as inhibition of capsaicin-stimulated response by aequorin and CRE-lucifear...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM585737(US11530213, Example 58)
Affinity DataIC50:  17nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Bayer Yakuhin

Curated by ChEMBL
LigandPNGBDBM50382243(CHEMBL2024492)
Affinity DataIC50:  18nMAssay Description:Antagonist activity at human TRPV1 expressed in CHOluc9aeq cells assessed as inhibition of capsaicin-stimulated response by aequorin and CRE-lucifear...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholesteryl ester transfer protein(Homo sapiens (Human))
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50312718(CHEMBL479527 | torcetrapib)
Affinity DataIC50:  18nMAssay Description:Inhibition of CETP in human plasma measured every 30 mins for 120 mins by fluorescence methodMore data for this Ligand-Target Pair
TargetCholesteryl ester transfer protein(Homo sapiens (Human))
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50348228(CHEMBL1800807)
Affinity DataIC50:  18nMAssay Description:Inhibition of CETP in human plasma measured every 30 mins for 120 mins by fluorescence methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGonadotropin-releasing hormone receptor(Homo sapiens (Human))
Kyoto 619-0216

Curated by ChEMBL
LigandPNGBDBM50165518(1-tert-Butyl-3-[2-(2-methoxy-5-nitro-benzylsulfany...)
Affinity DataIC50:  18nMAssay Description:Inhibitory concentration against human leutinizing releasing hormone receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM585764(US11530213, Example 85)
Affinity DataIC50:  19nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGonadotropin-releasing hormone receptor(Rattus norvegicus)
Kyoto 619-0216

Curated by ChEMBL
LigandPNGBDBM50165530(6-(3-tert-Butyl-ureido)-2-(2-methoxy-5-nitro-benzy...)
Affinity DataIC50:  19nMAssay Description:Inhibitory concentration against rat leutinizing releasing hormone receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGonadotropin-releasing hormone receptor(Homo sapiens (Human))
Kyoto 619-0216

Curated by ChEMBL
LigandPNGBDBM50160511(1-Benzyl-2-[2-(3-tert-butyl-ureido)-ethyl]-1H-benz...)
Affinity DataIC50:  20nMAssay Description:Inhibitory concentration of the compound towards human leutinizing releasing hormone receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholesteryl ester transfer protein(Homo sapiens (Human))
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM124871(US8759365, 9-4 | US8759365, 9-5)
Affinity DataIC50:  21nMpH: 7.4 T: 2°CAssay Description:CETP Activity Kit (#RB-RPAK) was purchased from Roar Biochemical, Inc. (New York, N.Y., USA). To each well of a 96-well NBS half-area plate (costar #...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGonadotropin-releasing hormone receptor(Homo sapiens (Human))
Kyoto 619-0216

Curated by ChEMBL
LigandPNGBDBM50165538(6-(3-tert-Butyl-ureido)-2-(2-methoxy-5-nitro-benzy...)
Affinity DataIC50:  21nMAssay Description:Inhibitory concentration against human leutinizing releasing hormone receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGonadotropin-releasing hormone receptor(Rattus norvegicus)
Kyoto 619-0216

Curated by ChEMBL
LigandPNGBDBM50165553(6-(3-tert-Butyl-ureido)-2-(2-methoxy-5-nitro-benzy...)
Affinity DataIC50:  21nMAssay Description:Inhibitory concentration against rat leutinizing releasing hormone receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGonadotropin-releasing hormone receptor(Homo sapiens (Human))
Kyoto 619-0216

Curated by ChEMBL
LigandPNGBDBM50160515(1-Benzyl-2-[2-(3-tert-butyl-ureido)-ethyl]-1H-benz...)
Affinity DataIC50:  22nMAssay Description:Inhibitory concentration of the compound towards human leutinizing releasing hormone receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM585760(US11530213, Example 81)
Affinity DataIC50:  23nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCholesteryl ester transfer protein(Homo sapiens (Human))
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM124882(US8759365, 6)
Affinity DataIC50:  23nMpH: 7.4 T: 2°CAssay Description:CETP Activity Kit (#RB-RPAK) was purchased from Roar Biochemical, Inc. (New York, N.Y., USA). To each well of a 96-well NBS half-area plate (costar #...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGonadotropin-releasing hormone receptor(Homo sapiens (Human))
Kyoto 619-0216

Curated by ChEMBL
LigandPNGBDBM50165539(1-tert-Butyl-3-[1-butyl-2-(2-methoxy-5-nitro-benzy...)
Affinity DataIC50:  23nMAssay Description:Inhibitory concentration against human leutinizing releasing hormone receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGonadotropin-releasing hormone receptor(Rattus norvegicus)
Kyoto 619-0216

Curated by ChEMBL
LigandPNGBDBM50165528(6-(3-tert-Butyl-ureido)-2-(2-methoxy-5-nitro-benzy...)
Affinity DataIC50:  23nMAssay Description:Inhibitory concentration against rat leutinizing releasing hormone receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM585768(US11530213, Example 89)
Affinity DataIC50:  24nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM585694(5-(2,5,8,11,14,17- hexaoxanonadecan-19-yloxy)-8- c...)
Affinity DataIC50:  25nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM585709(8-chloro-1-(2,6-dichlorophenyl)-5- (2-(2-(2-(2- hy...)
Affinity DataIC50:  25nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCholesteryl ester transfer protein(Homo sapiens (Human))
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM124884(US8759365, 16-2)
Affinity DataIC50:  25nMpH: 7.4 T: 2°CAssay Description:CETP Activity Kit (#RB-RPAK) was purchased from Roar Biochemical, Inc. (New York, N.Y., USA). To each well of a 96-well NBS half-area plate (costar #...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM585722(3,5-dichloro-4-(8-chloro-5- (((3R,4S)-4- hydroxyte...)
Affinity DataIC50:  26nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGonadotropin-releasing hormone receptor(Homo sapiens (Human))
Kyoto 619-0216

Curated by ChEMBL
LigandPNGBDBM50165533(6-(3-tert-Butyl-ureido)-2-(2-methoxy-5-nitro-benzy...)
Affinity DataIC50:  27nMAssay Description:Inhibitory concentration against human leutinizing releasing hormone receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetG protein-activated inward rectifier potassium channel 1/4(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM585720(8-chloro-1-(2,6-dichlorophenyl)-5- (3-hydroxy-2-(h...)
Affinity DataIC50:  28nMAssay Description:Quattro is controlled using IonWorks v2 software to perform the following steps:a. Add 3.5 ul cells plus 3.5 ul external buffer to wells of Quattro P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 377 total ) | Next | Last >>
Jump to: